TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Device elapsed time to respond to SpO2 alarm
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cold-inducible RNA binding protein levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with newly diagnosed cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Sign Language Skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Teaching Behaviors
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Total number of patients with Riker sedation-agitation score ≥5
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall response rate (ORR) of AZD4573 in combination with acalabrutinib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive Affect and Well-Being
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-Traumatic Stress Disorder symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Sleep Disturbance Scale for Children (SDSC)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in the Percentage of Acceptance of the Video Interaction Project
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Parenting practices in Cognitive stimulation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Changes in Parent-child interactions during reading
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Parent Reading Belief of their children
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of pregnancies of women with MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Risk of pre-defined adverse pregnancy outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Annual number of pregnancies of women with MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Proportion of participants who achieve clinical remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anti-glycoprotein E antibody Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change from baseline Blood glucose response at 2 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: The incidences of adverse maternofetal outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Clock drawing test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complex figure test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: blood sugar variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Posttetanic count (PTC) measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neuromuscular outcomes
Primary endpoint: Maximum unilateral knee extension strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in Strength of lower limb
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change in partial mayo score index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Death from Any Cause
Endpoint domain: Mortality/survival
Primary endpoint: Death from Cardiovascular Cause
Endpoint domain: Mortality/survival
Primary endpoint: Change in symptoms of emotional dysregulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intracranial objective response rates (iORR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Proportion of patients with iron deficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Microcirculatory changes in skin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Changes in skin and core temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth Activity Profile (YAP)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Seroprotection/vaccine-response rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Impedance across different types of tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness Rate of Treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change from Baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Temporomandibular joint disorder severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Masticator muscle pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Canadian Occupational Performance Measure - COPM
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Performance Quality Rating Scale - PQRS
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: The Child and Adolescent Scale of Participation - CASP
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Pediatric Quality of Life Inventory - PedsQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: intestinal health
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Leg discomfort related to CVD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in the fatty acid desaturation index (FADI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in phosphatidylcholine (PC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Maximum pain reported during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endothelial glycocalyx layer shedding markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: airway difficult score (ADS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intubation difficulty scale (IDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of glottic opening (POGO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height intervention questionnaire
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective fear rating during height exposure
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Harvard Group Scale of Hypnotic Susceptibility
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of participants who achieve treatment goals
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Post-Prandial Sensor Glucose Readings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from baseline PROMIS-Global Health score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change in the levels of physical fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of memantine and donpezil
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes and Consciousness Awareness Scale for Gender Equality
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Knowledge Scale for Gender Equality
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Self-Attitude toward Gender Roles
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to Maximum Plasma Concentration (Tmax) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 to the time of Last Quantifiable Concentration (AUC0-t) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Curve From Time 0 Extrapolated to Infinity (AUCinf) of Emraclidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dengue vaccine hesitancy score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of nasal and oropharyngeal bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: Total volume of Drain Fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight (Kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety as determined by dose limiting toxicities (DLTs)
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of DSM 5 psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk factors for DSM 5 psychiatric disorders
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of Intervention (FIM)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of Intervention (Study Retention)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Acceptability of Intervention (AIM)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Acceptability of Intervention (EMA Completion Rates)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Lumper puncture opening pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual disturbance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with a gain in Best Corrected Visual Acuity (BCVA) of ≥15 ETDRS letters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in BCVA from baseline to Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants With Newly Occurring Notable Abnormal Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline depression and anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change from baseline quality of life (QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Dermal water content measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum osmolality as a laboratory biomarker of dehydration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical dehydration assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with myelotoxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Wound QOL Survey Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: PUSH Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain With Dressing Changes
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Toxicity prediction
Endpoint domain: Adverse events/effects
Primary endpoint: Blood pressure of the brachial artery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in state anxiety as assessed by the Liebowitz Social Anxiety Scale-Self Report version (LSAS-SR)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in depressive symptoms as assessed by score on the Patient Health Questionnaire-4 (PHQ-4)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Diabetic Foot Infection (DFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Global Acne Grading Classification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Child acceptability score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Visual analogue scale (VAS)-3H
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Early detection of Acute Kidney Injury (AKI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Progression of axial length
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change From Baseline in Episcleral Venous Pressure (EVP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Change From Baseline in Trabecular Outflow Facility
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Proportion of foods tolerated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: spirometric indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of early day hypoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Efficacy and safety of bIAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with good embryo quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Prevalence of Gastroesophageal reflux disease (GERD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Alpha and Beta diversity of Fecal bacteriome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbiome outcomes
Primary endpoint: Alpha and Beta diversity of Fecal fungome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbiome outcomes
Primary endpoint: Alpha and Beta diversity of Fecal virome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Microbiome outcomes
Primary endpoint: Cross Cultural Adaptability Inventory (CCAI)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Psychological Well-Being Scale (PWS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean Condom Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Report Change in PrEP Awareness
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Report Change in PrEP Access
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants Who Report Changes in PrEP Use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of Participants Who Report Change in HIV Testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean Change in HIV Test Perception Score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in cycloplegic Refraction Error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of early neurological deterioration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of venous thrombosis events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Infection in the obstetric tear
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence Rate of Clinical Stroke or TIA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Hearing Handicap Inventory for Elderly (HHIE)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in International Outcome Inventory for Hearing Aids (IOI-HA)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent heavy (binge) days drinking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days to first use
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Immunological indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Time of hospital discharge
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Improvement in GERD-Health Related Quality of Life (HRQL) questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in Reflux Symptom Index (RSI) questionnaire scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Evaluation of MSC culture passage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of atrial tachycardia arrhythmias
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fat Free Mass Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adherence to the intermittent fasting program
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of HCV cured PWUD participants (SVR12)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Feasibility of tool use by surrogate decision-makers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Feasibility of enrolling surrogates in a clinical trial
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of retaining surrogates in a neurocritical care setting
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change from Baseline in ISNCSCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: activation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum deformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety and tolerability of NUV-1511
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of NUV-1511 in advanced solid tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change in Quad Medication Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Patients in Sinus Rhythm
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in function on the Oswestry Disability Index (ODI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Perivascular coronary fat attenuation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Assessment of parkinsonian motor speech features (hypokinetic dysarthria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of acoustic and linguistic speech features as proxy for behavior and cognitive changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Safety of daily administration of tricaprilin
Endpoint domain: Adverse events/effects
Primary endpoint: Cost per healthy year gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Diabetic Foot Knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Foot Care Behavior
Endpoint domain: Life impact
Endpoint subdomain: Behavioral functioning
Primary endpoint: Arterial Blood Gas Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction/Regret about the decision
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thrombosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Latency to central nervous system oxygen toxicity (CNSOT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in Adoption
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Change in Fidelity
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Percent change of serum TTR concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose of GPC2 CAR T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of Adverse Events Following GPC2 CAR T cell administration
Endpoint domain: Adverse events/effects
Primary endpoint: Number of atrial fibrillation (AF) recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Safety of EV-Pure™ and WJ-Pure™ administration
Endpoint domain: Adverse events/effects
Primary endpoint: Efficacy of EV-Pure™ and WJ-Pure™
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration vs. time curve in plasma from zero to infinity (AUCu)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in rate of progression of breast arterial calcification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in Eating Disorder symptomatology (drive for thinness)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Eating Disorder symptomatology (body dissatisfaction)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in body mass index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-curve from Zero to the Last Quantifiable Concentration (AUClast) of BGF MDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes